Vertex Pharmaceuticals (VRTX) Change in Inventory (2011 - 2026)

Vertex Pharmaceuticals' Change in Inventory history runs 16 years deep, the most recent figure standing at $97.7 million for Q1 2026.

• In Q1 2026, Change in Inventory fell 41.53% year-over-year to $97.7 million; the TTM figure through Mar 2026 stood at $454.8 million (down 24.74% YoY), while the FY2025 annual figure was $524.2 million, up 1.33% from the prior year.
• Change in Inventory for Q1 2026 stood at $97.7 million, up from $77.4 million in the prior quarter.
• The five-year high for Change in Inventory was $182.5 million in Q3 2024, with the low at -$2.0 million in Q1 2022.
• The 5-year median for Change in Inventory is $82.6 million (2023), against an average of $94.0 million.
• The sharpest annual moves came in 2022 and 2023: Change in Inventory plunged 108.77% in 2022, then jumped 4230.0% in 2023.
• Vertex Pharmaceuticals' Change in Inventory stood at $78.3 million in 2022, then slipped by 10.6% to $70.0 million in 2023, then surged by 110.71% to $147.5 million in 2024, then slumped by 47.53% to $77.4 million in 2025, then grew by 26.23% to $97.7 million in 2026.
• Business Quant data shows VRTX's Change in Inventory at $97.7 million in Q1 2026, $77.4 million in Q4 2025, and $131.1 million in Q3 2025.